×

Covetrus Poised For Re-Rating Driven By Upbeat Outlook

Published Sep 28 2020 at 4:36 PM GMT
Key
Points
  • (NASDAQ : CVET; $22.98; Market Capitalization: $2.
  • 6 billion) is on a path of fast-tracked recovery as the company has managed to successfully reboot its operations in the U S, where COVID-19 lockdowns dented demand for veterinary wellness visits in 1Q20.




Trending

Stats

  • Published Sep 28, 2020 4:36 PM GMT